Phase II trial of BKM120 and Docetaxel in patients with chemotherapy naïve castrate resistant Metastatic prostate cancer (BuDoP trial)
Sponsor: The University of Arizona Cancer Center
Protocol number: BKM120
Projected enrollment dates: January 2015 to December 2016
Official study title: Phase II trial of BKM120 and Docetaxel in patients with chemotherapy naïve castrate resistant Metastatic prostate cancer (BuDoP trial)
ClinicalTrials.gov page:
http://www.clinicaltrials.gov/show/Pending